Download Image
    
Share
  
Post
Vadadustat for COVID-19
1 study with 448 patients
Hospital Icon Control
Hospital Icon Vadadustat Serious Outcome Risk
No significant improvements are seen in meta analysis to date.
COVID-19 Vadadustat studies. Nov 2025. c19early.org
0 0.5 1 1.5+ All studies -3% Mortality -3% RCTs -3% Late -3% Favorsvadadustat Favorscontrol
Mar 25
 Bobrow et al., NCT04478071 Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
3% higher mortality (p=1), 16% lower progression (p=0.36), and 8% improved recovery (p=0.6). RCT 448 hospitalized COVID-19 patients in the USA showing no significant differences with vadadustat.